In summary, CD8α ALN-1 promotes proliferation and effector functionality of antitumor CD8+ T cells and synergizes with CD13 AFR to mediate complete tumor eradication, allowing protection against secondary challenge. This evidence concerns the gene CD8A and neoplasm.